En Carta Diagnostics vs MindImmune
En Carta Diagnostics vs MindImmune, compared side by side on 15 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: En Carta Diagnostics is on 52/100 and MindImmune on 53/100.
Where each one leads
En Carta Diagnostics
Leads on none of the measures we hold for both companies.
MindImmune
- domain rating: 23/100 against 0/100
- funding raised: $35.0M against $5.0M
At a glance
| Measure | En Carta Diagnostics | MindImmune |
|---|---|---|
| What it is | Developing a new generation of molecular diagnostics for at-home use, combining laboratory accuracy with rapid test simplicity. | Developing AI-powered diagnostics for neurodegenerative diseases. |
| Category | Biotechnology, HealthTech, Diagnostics, Medical Devices | Biotechnology, Artificial Intelligence, Healthcare, Diagnostics |
| Sells toBusiness model | B2B2C | B2B |
| Offering | Hardware | Software |
| Founded | 2022 | 2021 |
| Headquarters | Paris, France | Paris, France |
| Status | Inactive | Active |
Size, funding and growth
| Measure | En Carta Diagnostics | MindImmune |
|---|---|---|
| Employees | 12 | Not published |
| Total funding | $5.0M | $35.0M |
| Latest round | Seed | Strategic Investment |
| Valuation | Not published | $1.1B |
| LinkedIn followers | 2,091 | Not published |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | En Carta Diagnostics | MindImmune |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 52/100 | 53/100 |
| Traction | 45/100 | 38/100 |
| Team | 70/100 | 60/100 |
| Search visibility | 20/100 | 3/100 |
| Quality | 58/100 | 68/100 |
| Agent readinessHow well an AI agent can read and act on the site | Not published | F (33/100) |
| Domain ratingLink authority, 0-100 | 0/100 | 23/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | En Carta Diagnostics | MindImmune |
|---|---|---|
| CDN | Not detected | Cloudflare |
| CMS | Not detected | Webflow |
En Carta Diagnostics vs MindImmune: common questions
Which is better, En Carta Diagnostics or MindImmune?
On our 0-100 score MindImmune rates higher (53/100 against 52/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 15 data points above: read the rows that match what you are buying for.
How do En Carta Diagnostics and MindImmune compare on the numbers?
MindImmune leads on domain rating (23/100 against 0/100), funding raised ($35.0M against $5.0M).
Read the full En Carta Diagnostics review and pricing or the MindImmune review and pricing. You can also browse other En Carta Diagnostics alternatives we track.